Multiple Myeloma clinical trials in Alaska

4 actively recruiting multiple myeloma trials at 2 sites across Alaska.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in diff…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT03937635

Sites in Alaska:

Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Anchorage Radiation Therapy Center — Anchorage, Alaska
Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Alaska Oncology and Hematology LLC — Anchorage, Alaska
Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of c…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT04566328

Sites in Alaska:

Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Anchorage Radiation Therapy Center — Anchorage, Alaska
Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Alaska Oncology and Hematology LLC — Anchorage, Alaska
Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are consid…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT05561387

Sites in Alaska:

Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Anchorage Radiation Therapy Center — Anchorage, Alaska
Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Alaska Oncology and Hematology LLC — Anchorage, Alaska
Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Alaska:

Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Anchorage Radiation Therapy Center — Anchorage, Alaska
Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Alaska Oncology and Hematology LLC — Anchorage, Alaska
Alaska Women's Cancer Care — Anchorage, Alaska

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20